Updated on 21 July 2025
NANOCOMBO project: exploring opportunities in drug repurposing associated with multi-drug combination
CEO at THERIOPHARM
Wavre, Belgium
About
Drug combination is a very powerful approach to design and tailor efficient treatment . Our nanodrop technology have the same size than a coronavirus and can be loaded with targeting synthons (RGD peptide, for example).
We are looking for academics/SMEs interested in exploring with us our NANOCOMBO approach. Our technology is suitable for any administration route in any therappeutic field.
Stage
- Early
Attached files
Similar opportunities
Project cooperation
- Early
- Research
Dr Raphaël Duval
CEO at THERIOPHARM
Wavre, Belgium
Project cooperation
Glycolipids / glycopeptides or lipopeptides from food waste
Dr Raphaël Duval
CEO at THERIOPHARM
Wavre, Belgium
Partnership
Thomas Wolfinger
Projectmanager at Interreg CE project VReduMED
Linz, Austria